Pyrimidine derivatives as 11beta-HSD1 inhibitors
Details for Australian Patent Application No. 2005256442 (hide)
International Classifications
Event Publications
11 January 2007 PCT application entered the National Phase
PCT publication WO2006/000371 Priority application(s): WO2006/000371
22 February 2007 Change of Name(s) of Applicant(s), Section 104
F.Hoffmann-La Roche AG The name of the applicant has been changed to F. Hoffmann-La Roche AG
12 February 2009 Application Accepted
Published as AU-B-2005256442
11 June 2009 Standard Patent Sealed
Legal
The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.
Next and Previous Patents/Applications
2005256468-Novel use of peptide compounds for treating essential tremor and other tremor syndromes
2005256426-3'-alkoxy spirocyclic tetramic and tetronic acids
IP Reporting Samples
Customised IP Reporting
IP Insider for IP Professionals
IP Monitor Professional
- Editable Word format reports
- For IP Professionals
- Multiuser